Bio-Rad Laboratories (BIO) EPS (Diluted) Growth (1y) (2010 - 2026)
Powered by 
Analysis
Bio-Rad Laboratories (BIO) EPS (Diluted) Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 10.71% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 59.30% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 8.50% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -9.61% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 1.14% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 180.73% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 18.67% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -66.39% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -149.73% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -924.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.67% |
| Mar 31, 2026 | -954.05% |
| Dec 31, 2025 | 204.03% |
| Sep 30, 2025 | -154.41% |
| Jun 30, 2025 | 115.30% |
| Mar 31, 2025 | -82.98% |
| Dec 31, 2024 | -311.89% |
| Sep 30, 2024 | 541.93% |
| Jun 30, 2024 | -92.62% |
| Mar 31, 2024 | 480.29% |
| Dec 31, 2023 | -56.92% |
| Sep 30, 2023 | 166.40% |
| Jun 30, 2023 | -27.51% |
| Mar 31, 2023 | 102.06% |
| Dec 31, 2022 | 153.64% |
| Sep 30, 2022 | -104.21% |
| Jun 30, 2022 | -202.40% |
| Mar 31, 2022 | -447.43% |
| Dec 31, 2021 | -284.50% |
| Sep 30, 2021 | 197.79% |